U.S. drugmaker Biogen Inc and gene-editing startup Scribe Therapeutics Inc will jointly develop therapies for treating underlying genetic causes of amyotrophic lateral sclerosis (ALS), a fatal ...
AI in cancer diagnostics is changing the way doctors find and treat cancer. It’s not just about fancy machines—it’s about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback